The hydroxychloroquine trial is led by McGill.
A drug that the US president has been talking up is actually being tested on Canadians. A giant study is testing hydroxychloroquine in Canada, and they’re recruiting volunteers right now. People in Alberta, Manitoba, and Quebec who have been exposed to COVID-19 are invited to join their clinical trial.
The McGill-lead study has three branches taking place in Calgary, Montreal, and Ontario.
They started recruiting volunteers on Tuesday, March 17, and Dr. Ilan Schwartz, the principal investigator of the Albertan arm, told Narcity that results could come in just weeks.
“There’s interest in hydroxychloroquine (HCQ) as a potential intervention to treat and perhaps prevent COVID-19,” said Schwartz. “But we have no idea if it truly works in people.”
HCQ is an antiviral drug normally used to treat malaria or lupus. But now, scientists and politicians are arguing whether it’s good for COVID-19 too.
They plan to test 1,500 patients, with a possible scale-up to 3,000, across Canada. Schwartz said there are already 757 people enrolled.
The goal isn’t to test